Terns Pharmaceuticals Inc (TERN NASDAQ) stock market data APIs
$35.8799
2.17(6%)
as of February 4, 2026
Try our APIs with
free plan!
Terns Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Prev. Close
35.8799
Open
38.0451
High
38.8999
Low
35.44
52 wk Range
1.865-48.26
Market Cap
3 922 M
Shares Outstanding
109 M
Revenue
1 000 K
EPS
-0.27
Beta
-0.285
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Terns Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Terns Pharmaceuticals Inc data using free add-ons & libraries
Get Terns Pharmaceuticals Inc Fundamental Data
Terns Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 1 000 K
- EBITDA: -108 331 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-10
- EPS/Forecast: -0.3021
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Terns Pharmaceuticals Inc News
New
Terns Pharmaceuticals (TERN) Valuation Check After Expanded Global Rights To TERN-701
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Terns Pharmaceuticals (TERN...
Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is included in our list of the 11 Best Performing Stocks in the Last 12 Months.Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Se...
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 14 best booming stocks to buy right now. On January 8, Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on the stock with a ...
Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 20 Best Performing Stocks in 2025.Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN) On December 11, 2025, TheFly rep...
Get Terns Pharmaceuticals Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
